help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 23, 2004
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-0857
A more recent version of this article appeared on February 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/2/1181    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, S.
Right arrow Articles by Owen, G. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, S.
Right arrow Articles by Owen, G. I

Submitted on May 10, 2004
Accepted on October 18, 2004

Progesterone increases Tissue Factor gene expression, procoagulant activity and invasion in the breast cancer cell line ZR-75-1

Sumie Kato, Mauricio Pinto, Andrés Carvajal, Natalia Espinoza, Carolina Monso, Anil Sadarangani, Manuel Villalon, Jan J Brosens, John O White, Jennifer K Richer, Kathryn B Horwitz, and Gareth I Owen*

Unidad de Reproducción y Desarrollo, Facultad de Ciencias Biológicas, Departamento de Obstetricia y Ginecologia, Facultad de Medicina, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile; Institute of Reproductive and Developmental Biology, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom; Department of Medicine, Division of Endocrinology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA

* To whom correspondence should be addressed.
Gareth I Owen, E-mail: gowen{at}bio.puc.cl

Progesterone in hormonal preparations increases the incidence of breast cancer. Tissue factor (TF), the initiator of the extrinsic coagulation pathway, is associated with metastasis in a wide variety of cancers. We demonstrate herein that TF mRNA and protein is up-regulated by progesterone in the breast cancer cell line ZR-75. EGF, also associated with increased breast cancer risk, did not regulate TF. The increase in TF is both rapid and transient; increasing after 6 h, reaching a maximum at 24 h, before decreasing to basal levels at 72 h. Sucrose gradient experiments demonstrated that TF is located in the heavy fraction of the plasma membrane, although caveolin-1 is not expressed in ZR-75. To understand the physiological implications of an increase in TF we performed coagulation and invasion assays. An increase in TF corresponded to an increase in procoagulant activity. Furthermore, progesterone increased the invasion of ZR-75 cells through a matrigel, an effect which was blocked by an antibody against TF. As TF expression is associated with an enhanced risk of metastasis, we postulate that the progesterone-dependent up-regulation of TF provides a survival advantage to burgeoning breast cancer cells and may contribute to the increased risk of cancer associated with combined HRT.


Key words: Tissue factor • progesterone • EGF • caveolin-1 • breast cancer




This article has been cited by other articles:


Home page
Cancer Res.Home page
E. Bicaku, D. C. Marchion, M. L. Schmitt, and P. N. Munster
Selective Inhibition of Histone Deacetylase 2 Silences Progesterone Receptor-Mediated Signaling
Cancer Res., March 1, 2008; 68(5): 1513 - 1519.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society